Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $1,683 | $2,621 | $1,152 | $1,899 |
| - Cash | $183 | $226 | $286 | $379 |
| + Debt | $76 | $85 | $94 | $95 |
| Enterprise Value | $1,576 | $2,480 | $960 | $1,615 |
| Revenue | $377 | $313 | $245 | $204 |
| % Growth | 20.3% | 27.7% | 20.4% | – |
| Gross Profit | $191 | $133 | $90 | $84 |
| % Margin | 50.7% | 42.6% | 36.6% | 41.4% |
| EBITDA | -$52 | -$177 | -$174 | -$212 |
| % Margin | -13.8% | -56.5% | -71.1% | -104% |
| Net Income | -$78 | -$209 | -$205 | -$218 |
| % Margin | -20.6% | -66.7% | -83.5% | -107% |
| EPS Diluted | -1.3 | -3.6 | -3.6 | -4.04 |
| % Growth | 63.9% | 0% | 10.9% | – |
| Operating Cash Flow | -$48 | -$64 | -$142 | -$124 |
| Capital Expenditures | -$28 | -$5 | -$28 | -$102 |
| Free Cash Flow | -$76 | -$69 | -$170 | -$226 |